Evidence map›Paper›PMID 37922688›Full record

ArticleESMO open2023

Chronic fatigue in childhood cancer survivors is associated with lifestyle and psychosocial factors; a DCCSS LATER study.

A Penson, I Walraven, E Bronkhorst, M A Grootenhuis, H Maurice-Stam, I de Beijer, M van der Heiden-van der Loo, W J E Tissing, H J H van der Pal, A C H de Vries and 13 more

Open access · goldAbstract read
In one paragraph

Article in ESMO open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Metabolic Implications of Childhood Cancer.Current pediatrics reports · 2025
    Article
  10. Connecting the dots: the role of fatigue in female infertility.Reproductive biology and endocrinology : RB&E · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 8 institutions in 3 countries.

A PensonRadboud University Medical Center, Center of Expertise for Cancer Survivorship, Department of Hematology, Nijmegen. Electronic address: adriaan.penson@radboudumc.nl.
I WalravenDepartment for Health Evidence, Radboud University Medical Center, Nijmegen.
E BronkhorstDepartment for Health Evidence, Radboud University Medical Center, Nijmegen.
M A GrootenhuisPrincess Máxima Center for Pediatric Oncology, Utrecht.
H Maurice-StamPrincess Máxima Center for Pediatric Oncology, Utrecht.
I de BeijerPrincess Máxima Center for Pediatric Oncology, Utrecht.
M van der Heiden-van der LooPrincess Máxima Center for Pediatric Oncology, Utrecht.
W J E TissingPrincess Máxima Center for Pediatric Oncology, Utrecht; Department of Pediatric Oncology/Hematology, Beatrix Children's Hospital/University of Groningen/University Medical Center Groningen, Groningen.
H J H van der PalPrincess Máxima Center for Pediatric Oncology, Utrecht.
A C H de VriesPrincess Máxima Center for Pediatric Oncology, Utrecht; Department of Pediatric Oncology, Erasmus Medical Center, Rotterdam, The Netherlands.
D BrestersPrincess Máxima Center for Pediatric Oncology, Utrecht.
C M RonckersPrincess Máxima Center for Pediatric Oncology, Utrecht; Division of Childhood Cancer Epidemiology, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
M M van den Heuvel-EibrinkPrincess Máxima Center for Pediatric Oncology, Utrecht; Department of Pediatric Oncology, Erasmus Medical Center, Rotterdam, The Netherlands; Wilhelmina Children's Hospital, UMCU, Utrecht.
S NeggersPrincess Máxima Center for Pediatric Oncology, Utrecht; Department of Medicine, Section Endocrinology, Erasmus Medical Center, Rotterdam.
B A B VersluysPrincess Máxima Center for Pediatric Oncology, Utrecht.
M LouwerensLeiden University Medical Center, Department of Internal Medicine, Leiden.
S M F PluijmPrincess Máxima Center for Pediatric Oncology, Utrecht.
N BlijlevensRadboud University Medical Center, Center of Expertise for Cancer Survivorship, Department of Hematology, Nijmegen.
E van Dulmen-den BroederDepartment of Pediatric Oncology/Hematology, Amsterdam University Medical Center, Amsterdam.
L C M KremerPrincess Máxima Center for Pediatric Oncology, Utrecht; Department of Pediatric Oncology, Emma Children's Hospital, University of Amsterdam, Amsterdam.
H KnoopDepartment of Medical Psychology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.
J LoonenRadboud University Medical Center, Center of Expertise for Cancer Survivorship, Department of Hematology, Nijmegen.
Dutch LATER study group
Princess Máxima Center · NLRadboud University Nijmegen · NLErasmus MC · NLAmsterdam University Medical Centers · NLEmma Kinderziekenhuis · NLJohannes Gutenberg University Mainz · DELeiden University Medical Center · NLUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe purpose of this study was to determine factors associated with chronic fatigue (CF) in childhood cancer survivors (CCS). PATIENTS AND

methodsParticipants were included from the Dutch Childhood Cancer Survivor Study (DCCSS) LATER cohort, a nationwide cohort of CCS (≥5 years after diagnosis) and siblings as controls. Fatigue severity was assessed with the 'fatigue severity subscale' of the Checklist Individual Strength ('CIS-fatigue'). CF was defined as scoring ≥35 on the 'CIS-fatigue' and having fatigue symptoms for ≥6 months. Twenty-four parameters were assessed, categorized into assumed fatigue triggering, maintaining and moderating factors. Multivariable logistic regression analyses were carried out to investigate the association of these factors with CF.

resultsA total of 1927 CCS participated in the study (40.7% of invited cohort), of whom 23.6% reported CF (compared with 15.6% in sibling controls, P < 0.001). The following factors were associated with CF: obesity [versus healthy weight, odds ratio (OR) 1.93; 95% confidence interval (CI) 1.30-2.87], moderate physical inactivity (versus physical active, OR 2.36; 95% CI 1.67-3.34), poor sleep (yes versus no, OR 2.03; 95% CI 1.54-2.68), (sub)clinical anxiety (yes versus no, OR 1.55; 95% CI 1.10-2.19), (sub)clinical depression (yes versus no, OR 2.07; 95% CI 1.20-3.59), pain (continuous, OR 1.49; 95% CI 1.33-1.66), self-esteem (continuous, OR 0.95; 95% CI 0.92-0.98), helplessness (continuous, OR 1.13; 95% CI 1.08-1.19), social functioning (continuous, OR 0.98; 95% CI 0.97-0.99) and female sex (versus male sex, OR 1.79; 95% CI 1.36-2.37).

conclusionCF is a prevalent symptom in CCS that is associated with several assumed maintaining factors, with lifestyle and psychosocial factors being the most prominent. These are modifiable factors and may therefore be beneficial to prevent or reduce CF in CCS.

Indexed as

Cancer SurvivorsFatigue Syndrome, ChronicNeoplasmsSleep Wake DisordersChildDepressionFemaleHumansLife StyleMaleQuality of Lifechildhood cancerchronic fatiguelate effectssurvivorship

Identifiers

PMID37922688
PMCPMC10774970
OpenAlexW4388246701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.